Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial

Authors

Institutions

Publication Details

Journal
Radiation Oncology
Published
2025-04-18
DOI
https://doi.org/10.1186/s13014-025-02604-z
Citations
3
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial

Yuanji Xu, Xiaomin Wang, Zhiyong Zheng, Shi‐Hong Luo et al.
3 citations
Radiation Oncology
Esophageal Cancer Research and Treatment
6.02
article

Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial

Yuanji Xu, Xiaomin Wang, Zhiyong Zheng, Shi‐Hong Luo, Yunxiao Wang, Haihua Yang, Xia Wu, Meiling Chen, Jianyang Wang, Qin Du, Qing Qi, Wenyan Pan, Pengfei Gu, Yu‐Pei Yuan
article en
3 citations

Abstract

No abstract available for this paper.
Radiation OncologyVol. 20(1)
Fujian Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Wenzhou Medical University (CN), National Cancer Center (US), First Affiliated Hospital of Xinxiang Medical University (CN), Ningxia Medical University (CN), Ningxia Medical University General Hospital (CN), Affiliated Hospital of Hebei University (CN), Fujian Provincial Cancer Hospital (CN), Affiliated Hospital of Jining Medical University (CN), Anyang Tumor Hospital (CN), Henan Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 4%
Esophageal Cancer Research and Treatment
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial — Yuanji Xu, Xiaomin Wang, et al. · Radiation Oncology (2025) | TGRS Research Map | TGRS